连续性肾脏替代治疗对血栓性微血管病治疗的临床分析

蔡莹; 唐琳; 钟玲; 冯利平; 雷建蓉; 胡廷海; 廖晓辉

doi:10.13406/j.cnki.cyxb.2011.04.014

您当前的位置：

首页 >

文章列表页 >

连续性肾脏替代治疗对血栓性微血管病治疗的临床分析

临床研究 | 更新时间：2024-01-17

- 连续性肾脏替代治疗对血栓性微血管病治疗的临床分析
- The clinical analysis of patients with thrombotic microangiopathy by continuous renal replacement therapy
- 重庆医科大学学报 2011年36卷第4期页码：490-493
- 作者机构：
  
  重庆医科大学附属第二医院肾内科
- 作者简介：
- 基金信息：
  
  重庆医科大学校级课题资助项目（编号:XBYB2007032）
- DOI：10.13406/j.cnki.cyxb.2011.04.014
  中图分类号： R543
- 纸质出版日期：2011，
扫描看全文
[1]蔡莹,唐琳,钟玲,冯利平,雷建蓉,胡廷海,廖晓辉.连续性肾脏替代治疗对血栓性微血管病治疗的临床分析[J].重庆医科大学学报,2011,36(04):490-493.

CAI Ying, et al. The clinical analysis of patients with thrombotic microangiopathy by continuous renal replacement therapy[J]. Journal of Chongqing Medical University, 2011,36(4):490-493.
[1]蔡莹,唐琳,钟玲,冯利平,雷建蓉,胡廷海,廖晓辉.连续性肾脏替代治疗对血栓性微血管病治疗的临床分析[J].重庆医科大学学报,2011,36(04):490-493. DOI： 10.13406/j.cnki.cyxb.2011.04.014.

CAI Ying, et al. The clinical analysis of patients with thrombotic microangiopathy by continuous renal replacement therapy[J]. Journal of Chongqing Medical University, 2011,36(4):490-493. DOI： 10.13406/j.cnki.cyxb.2011.04.014.

摘要

目的:观察连续性肾脏替代治疗（Continuous renal replacement therapy

CRRT）对血栓性微血管病（Thrombotic microan-giopathy

TMA）的治疗效果。方法:对我院10例经CRRT治疗的TMA患者的临床资料进行回顾性分析。结果:10例患者存活7例

存活率为70%

存活者中3例治愈

4例好转

好转者中2例继续治疗基础疾病

2例慢性肾衰竭摆脱透析。治疗后存活患者实验室指标:Hb（107.1±26.8）g/L、Plt（162.6±73.0）×109个/L、血肌酐（Serum creatinine

Scr）（136.1±51.2）μmol/L、总胆红素（Total bilirubin

TBIL）（30.2±44.2）μmol/L、间接胆红素（Indirect bilirubinI

BIL）（10.1±4.2）μmol/L、乳酸脱氢酶（Lactate dehy-drogenase

LDH）（211.6±102.9）U/L较治疗前Hb（61.6±13.7）g/L、Plt（41.1±16.7）×109个/L、Scr（421.4±93.3）μmol/L、TBIL（140.6±149.2）μmol/LI、BIL（34.7±21.4）μmol/L、LDH（647.7±422.5）U/L明显好转（P<0.05）。结论:CRRT在临床上治疗TMA有效

有效降低死亡率。

Abstract

Objective:To observe the treatment effect on thrombotic microangiopathy(TMA) by continuous renal replacement therapy(CRRT).Methods:Retrospectively analyze the clinical data of 10 patients with thrombotic microangiopathy admitted to our hospital and treated by CRRT.Results:Seven cases of 10 patients survived

the survival rate was 70%.Among the survived patients

3 patients were cured

4 cases were improved.Among the 4 survived cases

2 patients continue to the treatment for the underlying disease

2 patients with chronic renal failure were independed on hemodialysis after treatment.Laboratory tests of survival patients after treatment

including Hb(88.6±16.4) g/L

Plt(162.6±73.0)×109/L

serum creatinine(Scr)(136.1±51.1) μmol/L

total bilirubin(TBIL)(30.2±44.2)μmol/L、indirect bilirubin(IBIL)(17.3±11.8) μmol/L

and lactate dehydrogenase(LDH)(254.0±150.1) U/L were significantly better than those before treatment(Hb(61.6±13.7) g/L

Plt(41.1±16.7)×109/L

Scr(421.4±93.3) μmol / L

TBIL(140.6±149.2) μmol/L

IBIL(95.3±104.6) μmol/L

LDH(647.7±150.1)U/L)(P<0.05).Conclusion:CRRT can be effective on the treatment of TMA and reduce mortality.

关键词

连续性肾脏替代治疗血栓性微血管病临床分析

Keywords

continuous renal replacement therapythrombotic microangiopathyclinical studies

references

浏览量

114

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

血栓性微血管病12例临床分析

不同抗凝策略在马蜂蜇伤患者CRRT治疗中的应用及护理